BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 27859061)

  • 1. Structural basis of collagen fiber degradation by cathepsin K.
    Aguda AH; Panwar P; Du X; Nguyen NT; Brayer GD; Brömme D
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17474-9. PubMed ID: 25422423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K.
    Law S; Panwar P; Li J; Aguda AH; Jamroz A; Guido RVC; Brömme D
    PLoS One; 2017; 12(10):e0186869. PubMed ID: 29088253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoactivated inhibition of cathepsin K in a 3D tumor model.
    Herroon MK; Sharma R; Rajagurubandara E; Turro C; Kodanko JJ; Podgorski I
    Biol Chem; 2016 Jun; 397(6):571-82. PubMed ID: 26901495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease.
    Obaha A; Novinec M
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric crosstalk in modular proteins: Function fine-tuning and drug design.
    Abhishek S; Deeksha W; Nethravathi KR; Davari MD; Rajakumara E
    Comput Struct Biotechnol J; 2023; 21():5003-5015. PubMed ID: 37867971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?
    González JEH; Salas-Sarduy E; Alvarez LH; Valiente PA; Arni RK; Pascutti PG
    Curr Med Chem; 2024; 31(16):2234-2263. PubMed ID: 37711130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Inhibitory Activity by Combining Allosteric Inhibitors Putatively Binding to Different Allosteric Sites on Cathepsin K.
    Sato S; Yamamoto K; Ito M; Nishino K; Otsuka T; Irie K; Nagao M
    Molecules; 2023 May; 28(10):. PubMed ID: 37241936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent applications of computational methods to allosteric drug discovery.
    Govindaraj RG; Thangapandian S; Schauperl M; Denny RA; Diller DJ
    Front Mol Biosci; 2022; 9():1070328. PubMed ID: 36710877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of noncompetitive inhibitors targeting an uncharacterized allosteric site of falcipain-2.
    Hernández González JE; Salas-Sarduy E; Hernández Alvarez L; Barreto Gomes DE; Pascutti PG; Oostenbrink C; Leite VBP
    J Comput Aided Mol Des; 2021 Oct; 35(10):1067-1079. PubMed ID: 34617191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Plasmodium dipeptidyl aminopeptidase allosteric inhibitors by high throughput screening.
    Sanchez MI; de Vries LE; Lehmann C; Lee JT; Ang KK; Wilson C; Chen S; Arkin MR; Bogyo M; Deu E
    PLoS One; 2019; 14(12):e0226270. PubMed ID: 31851699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
    Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
    PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases.
    Pant A; Kumar R; Wani NA; Verma S; Sharma R; Pande V; Saxena AK; Dixit R; Rai R; Pandey KC
    Sci Rep; 2018 Nov; 8(1):16193. PubMed ID: 30385827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational investigation of conformational variability and allostery in cathepsin K and other related peptidases.
    Novinec M
    PLoS One; 2017; 12(8):e0182387. PubMed ID: 28771551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An allosteric site enables fine-tuning of cathepsin K by diverse effectors.
    Novinec M; Rebernik M; Lenarčič B
    FEBS Lett; 2016 Dec; 590(24):4507-4518. PubMed ID: 27859061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational flexibility and allosteric regulation of cathepsin K.
    Novinec M; Kovacic L; Lenarcic B; Baici A
    Biochem J; 2010 Jul; 429(2):379-89. PubMed ID: 20450492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib.
    Law S; Andrault PM; Aguda AH; Nguyen NT; Kruglyak N; Brayer GD; Brömme D
    Biochem J; 2017 Feb; 474(5):851-864. PubMed ID: 28049758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods.
    Novinec M; Korenč M; Caflisch A; Ranganathan R; Lenarčič B; Baici A
    Nat Commun; 2014; 5():3287. PubMed ID: 24518821
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.